NG Biotech develops and manufactures novel in vitro diagnostic tools for therapy monitoring at the point of care (onsite), including a range of CE marked rapid tests. Its proprietary patented immunoassay platform enables the development of quantitative and multiplex point of care diagnostics and can be adapted to detect or monitor any kind of antibody, antigen, pathogen, parasite, hormone, or drug.